Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population

Medicina Clinica

Volumn 119, Issue 5, 2002, Pages 161-165

  Balada, Eva ^a   Ordi Ros, Josep ^a   Matas, Laia ^a   Mauri, Montse ^a   Buján, Segundo ^a   Vilardell Tarrés, Miguel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Anti OxLDL; Atherosclerosis; Older people

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; ANTIIDIOTYPIC ANTIBODY; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROSIS; BLOOD DONOR; CLEARANCE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY RISK; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; OXIDATIVE STRESS; RISK FACTOR; STATISTICAL ANALYSIS; CORONARY ARTERY ATHEROSCLEROSIS; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTI-IDIOTYPIC; CORONARY ARTERIOSCLEROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0037031105     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(02)73351-4     Document Type: Article

References (32)

1. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
2. The oxidation hypothesis of atherosclerosis
3. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice
4. Lipoprotein antibody immune complexes. Their catabolism and role in foam cell formation
5. Low density lipoprotein undergoes oxidative modification in vivo
6. Autoantilbody against oxidised LDL and progression of carotid atherosclerosis
7. Low-density lipoprotein oxidation in essential hypertension
8. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease
9. Serum antibodies to oxidized low density lipoprotein and ceroid in chronic periaortitis
10. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus
11. Autoantilbodies against oxidized low density lipoprotein in antiphospholipid syndrome
12. Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein
13. Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?
14. Autoantibodies against oxidatively modified low density lipoproteins in NIDDM
15. Antibodies against oxidised low density lipoprotein in juvenile chronic arthritis
16. Transient reduction of autoantibodies against oxidized LDL in patients with acute myocardial infarction
17. Autoantibodies against oxidized low-density lipoproteins in older stroke patients
18. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein
19. Prediction of coronary heart disease using risk factor categories
20. Occurren of anti-low density lipoprotein antibodies and circulating immune complexes in aged subjects
21. Increase in hydroxy fatty acids in human low density lipoproteins with age
22. Autoantibodies against oxidized LDL in the first phase of life. Low density lipoproteins
23. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease
24. Autoantibodies to OxLDL are decreased in individuals with borderline hypertension
25. Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non insulin-dependent diabetes mellitus
26. Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls
27. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus
28. Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty
29. Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia
30. Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke
31. Role of antioxidants in the prevention of cardiovascular disease
32. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition